The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
P38 MAP kinase is activated at early stages in Alzheimer's disease brain
Abstract
The regional, cellular, and subcellular localization of phosphorylated p38 MAPK (pp38) was examined by immunocytochemistry, immuofluorescent multiple labeling, and immunoblotting of extracts as well as immunoprecipitates of human postmortem tissue from control and Alzheimer's disease (AD) cases at different Braak stages. "Early AD" cases (Braak stages IV-V) and a subset of Braak stage VI cases have high levels of pp38 immunoreactivity, with the most dense immunoreactivity located in CA2 and subiculum followed by CA1 in the hippocampus. On the contrary, very little pp38 was detected in age-matched controls (Braak stages 0-II). More importantly, as revealed by various multiple labeling experiments, pp38 immunoreactivity is mainly located in neurons bearing early neurofibrillary pathology, but not in typically fibrillar tangles that are densely stained by thioflavin-S. Most pp38-positive neurons only contain a small amount of phospho-tau. Additionally, pp38 immunoreactivity was not associated with senile plaques. At the subcellular level, pp38-immunoreactive granules are usually larger than the granules stained with the lysosomal marker cathepsin D. Immunoblotting with different extraction buffers and immunoprecipitation indicate that pp38 does not or only loosely binds to phospho-tau. Taken together, this study demonstrates that p38 MAPK is activated at early stages of neurofibrillary degeneration in AD hippocampus. The p38 activation may also be linked to neurodegeneration thr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phospho-p38 is found exclusively in cells with NFT or tau aggregates in AD cases (152,153), co-localizes with tau aggregates in tauopathic brains (145,154) and co-precipitates with insoluble tau in both human cases and transgenic AD mouse models (145,148).”
From Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation (2011) · cites this paper as [153]
In the citing paper
“Since p38MAPK is a major regulator of SASP [209], it is not surprising that a number of key components of SASP appear to be up-regulated in AD [210,211].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [209]
In the citing paper
“Increased p38MAPK activity has been reported in AD brains and lymphocytes [205,206,207,208], as well as in the cortex of a mouse model of AD [209].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [209]
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Cataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-Isla, T., Hyman, B. T., & Nixon, R. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64538-5 · Cited by 776
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Matsuo, E. S., Shin, R.-W., Billingsley, M. L., Van deVoorde, A., O'Connor, M., Trojanowski, J. Q., & Lee, V. M. Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90264-x · Cited by 576
p38 MAP kinases: beyond the stress response
Nebreda, A. R., & Porras, A. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01595-4 · Cited by 550
Mielke, K., & Herdegen, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00042-8 · Cited by 490
Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404
Otvos, L., Feiner, L., Lang, E., Szendrei, G. I., Goedert, M., & Lee, V. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390607 · Cited by 488
Stadelmann, C., Deckwerth, T. L., Srinivasan, A., Bancher, C., Brück, W., Jellinger, K., & Lassmann, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65460-0 · Cited by 428
Silver staining of Alzheimer's neurofibrillary changes by means of physical development.
Gallyas, F. (1971) · PubMed · Cited by 411
Cited by
Li, S., Jin, M., Koeglsperger, T., Shepardson, N. E., Shankar, G. M., & Selkoe, D. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0203-11.2011 · Cited by 671
Diversity and versatility of p38 kinase signalling in health and disease
Canovas, B., & Nebreda, A. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00322-w · Cited by 657
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591
“Activated forms of p38 are found in the brains of AD mouse models and AD patients (Hensley et al., 1999; Zhu et al., 2000; Savage et al., 2002; Giovannini et al., 2002; Sun et al., 2003; Ferrer, 2004; Jin et al., 2005).”
BackgroundAgeing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Metadata
- Authors
- Sun, A.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Sun, A
- ORCID
- Sun, A
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 183
- Issue
- 2
- Pages
- 394-405
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2081858180
- Cited by
- 219
- References
- 35
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 14 · 2023: 16 · 2022: 11 · 2021: 14 · 2020: 21 · 2019: 11 · 2018: 9 · 2017: 13 · 2016: 6 · 2015: 5 · 2014: 8 · 2013: 9 · 2012: 9
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns039345-04)
- National Institute of Neurological Disorders and Stroke (3R01 NS 39345-01)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- p38 MAPK, Alzheimer's disease, neurofibrillary tangles, Braak stages, hippocampus, CA2, subiculum, CA1, phosphorylated tau, amyloid plaques, neurodegeneration, postmortem brain, subcellular localization, lysosomal granules, cathepsin D
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Enzyme Activation, Hippocampus, Humans, Middle Aged, Neurons, Parietal Lobe, Phosphorylation, Precipitin Tests, Neurofibrillary Tangles, tau Proteins, Disease Progression, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: P38 MAP kinase is activated at early stages in Alzheimer's disease brain. https://app.cochat.ai/papers/10.1016/s0014-4886(03)00180-8
- The paper
- Sun, A. (2003). P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Experimental Neurology. https://doi.org/10.1016/s0014-4886(03)00180-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.